Evelo Biosciences is dedicated to improving the lives of patients globally through the development of a new modality of medicines. The Company is harnessing the therapeutic potential of specific strains of naturally occurring microbes and developing them as a new class of medicines, monoclonal microbials. Evelo has validated that orally delivered monoclonal microbials modulate immunological and biological effects throughout the body after initial interactions with human cells in the gut. The Company is pioneering the development of this new class of medicine for the treatment of autoimmune, immunoinflammatory, metabolic, neurological, neuroinflammatory diseases and cancer.
|HQ||Cambridge, MA, US||Map|
|Employees (est.) (Feb 2019)||56|
Net income (FY, 2017)
EBIT (FY, 2017)
|Company Name||Date||Deal Size|
|Evelo Biosciences Security Corporation|
When was Evelo Biosciences founded?
Evelo Biosciences was founded in 2015.
How many employees does Evelo Biosciences have?
Evelo Biosciences has 56 employees.
Who are Evelo Biosciences competitors?
Competitors of Evelo Biosciences include Biocon, Livzon Pharmaceutical Group and Genentech.
Where is Evelo Biosciences headquarters?
Evelo Biosciences headquarters is located at 620 Memorial Dr, Cambridge.
Where are Evelo Biosciences offices?
Evelo Biosciences has an office in Cambridge.
How many offices does Evelo Biosciences have?
Evelo Biosciences has 1 office.
Receive alerts for 300+ data fields across thousands of companies